drugset / Trial / NCT00494091
Study Evaluating The Safety, Efficacy & Pharmacokinetics Of Temsirolimus(CCI-779) In Subjects With Advanced Renal Cell Carcinoma
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This is a study to evaluate the safety, efficacy and pharmacokinetics of temsirolimus in Asian patients with advanced renal cell carcinoma. The trial is only being conducted in Japan, Korea, and China.
Timeline
- Start
- 2007-02
- Primary completion
- 2011-05
- Completion
- 2012-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Temsirolimus | Small molecule | 20 mg/m2 | Intravenous |
| Subject | Temsirolimus | Small molecule | 25 mg | Intravenous |